Medtronic (NYSE: MDT)+
announced that it received regulatory approval in Japan for its Symplicity Spyral renal denervation (RDN) system.
GE HealthCare (Nasdaq: GEHC)+
announced that it received FDA 510(k) clearance for its Revolution Vibe CT imaging system.
Surgerii Robotics announced on LinkedIn today that its Shurui single-port surgical robot garnered CE mark approval in Europe.
A research team at UCLA, led by Professor Aydogan Ozcan, has introduced BlurryScope, a compact, cost-effective scanning microscope that combines simple optical hardware with advanced deep learning algorithms to assess HER2 status in breast cancer tissue samples.
Heart rate is one of the most basic and important indicators of health, providing a snapshot into a person’s physical activity, stress and anxiety, hydration level, and more.
A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of infection with the SARS-CoV-2 virus. The results of the placebo-controlled trial involving 450 healthy participants have now been published in JAMA Internal Medicine.
The submission for CT:VQ was supported by a clinical validation package that spanned a variety of lung conditions.
The technology is compatible with all PTFE grafts and was studied extensively in the company’s pivotal clinical trial
Imperative Care announced today that the FDA granted 510(k) clearance for its Symphony thrombectomy system to treat pulmonary embolism (PE).
Medtronic (NYSE: MDT)+
today announced major regulatory milestones for its MiniMed 780G automated insulin delivery system.